16/04/2018 14:17:17

Novo Nordisk A/S - Share repurchase programme

Related content
16 Jul - 
Novo Nordisk A/S - Share repurchase programme
09 Jul - 
Novo Nordisk A/S - Share repurchase programme
02 Jul - 
Novo Nordisk A/S - Share repurchase programme
Related debate
19 Jul - 
Ingen tvivl om at Novo går mod nye rekorder på lang sig..
18 Jul - 
Novo vil gå mod nye rekorder.
18 Jul - 
Jeg solgte 3 positioner i dag, men har stadig over 100 ..

Bagsværd, Denmark, 16 April 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 14 billion to be executed during a 12-month period beginning 1 February 2018.

Under the programme initiated 5 February 2018, Novo Nordisk will repurchase B shares for an amount up to DKK 2.5 billion in the period from 6 February 2018 to 30 April 2018.

Further information

Media:

 

 

Anne Margrethe Hauge +45 4442 3450

amhg@novonordisk.com

Ken Inchausti (US) +1 609 786 8316

kiau@novonordisk.com

 

 

 

Investors:

 

 
Peter Hugreffe Ankersen +45 3075 9085

phak@novonordisk.com

Anders Mikkelsen +45 3079 4461

armk@novonordisk.com

Christina Kjær +45 3079 3009

cnje@novonordisk.com

Company Announcement No 32 / 2018

CA20180416 Safe Harbour CA_UK


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Globenewswire

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
17 Jul
NOVO-B
Husk nu at lægge Levemir+Tresiba sammen, og så kan bedre forstå tallene ift. Lantus+Toujeo, særligt ..
8
15 Jul
NOVO-B
Når man er folkepensionist, er entry og exit mere vigtigt end køb langsigtet - så er 1. prioritet - ..
6
17 Jul
NOVO-B
hanfrank12, det er altså ikke optimalt, at bruge tal  for 2017 og Q1-2018 til at beskrive/konkludere..
5
18 Jul
NOVO-B
Novartis - en fedmekonkurrent mindre - kan tillægges triggersiden ;)   Novo-konkurrent skrotter udvi..
3
17 Jul
NOVO-B
Der er nu noget, der ikke stemmer helt!   Prøv og kik på Levemirs vækst fra Q1/17(4.012 mio. Kr.) - ..
3
16 Jul
NOVO-B
Berenberg hæver Novo-kursmål med 8 pct og gentager "hold"   Novo Nordisk har haft en kursmæssig fin ..
3
18 Jul
NOVO-B
Hvis du er hårdt eksponeret, kan det måske være en ide at sælge en portion med gevinst. Men ellers, ..
2
18 Jul
NOVO-B
Brud af gult trafiklys og det ser interessant ud. Spørgsmålet er om den bliver over den gamle nedtre..
2
17 Jul
NOVO-B
Du er som vanligt helt væk fra vinduet hanfrank1/2, kursen steg .90 % 😎
2
17 Jul
NOVO-B
TRESIBA - stiger på alle parametre - i følge recepttallene ... og ligger markant højere end Xultophy..
2

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
PIMCO Municipal Closed-End Funds Announce Intention to Conduct Tender Offers for Auction Rate Preferred Shares
2
Comstock Resources, Inc. Announces Pricing of $850 Million Private Offering of Senior Unsecured Notes Due 2026
3
ATOS : conference call on Monday July 23, 2018 at 08:00 am (CET - Paris)
4
WORLDLINE SA : Release of H1 2018 results changed to Monday July 23rd, 2018 at 6:30 am (CET-Paris)
5
AEGEAN MARINE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Aegean Marine Petroleum Network Inc. - ANW

Related stock quotes

Novo Nordisk B A/S 320.75 0.8% Stock price increasing
Novo Nordisk 49.94 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 July 2018 00:05:13
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180712.1 - EUROWEB1 - 2018-07-22 01:05:13 - 2018-07-22 00:05:13 - 1000 - Website: OKAY